Delgocitinib for Chronic Hand Eczema [ID6688]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Ruxolitinib for treating moderate atopic dermatitis [ID6602]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Topical tapinarof for treating atopic dermatitis in people 2 years and over [ID6713]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC